December 2015. Volume 11. Number 4

Vacunación de los prematuros. ¿Dónde está el peligro?

 
 
 
 
 
 
 
 
 
 
Rating: 0 (0 Votes)
Newsletter Free Subscription
Regularly recieve most recent articles by e-mail
Subscribe
Print
Add to library
Discuss this article

CA | Associated comment

Author: Ruiz Contreras J1.
1Servicio de Pediatría. Hospital Universitario 12 de Octubre. Madrid. España.
Correspondence: Jesús Ruiz Contreras. Email: jesus.ruiz@salud.madrid.org
Publication date: 16/12/2015

CA | Associated comment

Author: Ruiz Contreras J1.
1Servicio de Pediatría. Hospital Universitario 12 de Octubre. Madrid. España.
Correspondence: Jesús Ruiz Contreras. Email: jesus.ruiz@salud.madrid.org
Publication date: 16/12/2015

How to cite this article

Ruiz Contreras J. Vacunación de los prematuros. ¿Dónde está el peligro? Evid Pediatr. 2015;11:67.

References

  1. Mussi-Pinhata MM, Rego MAC. Immunological peculiarities of extremely preterm infants: a challenge for the prevention of nosocomial sepsis. J Pediatr (Rio J). 2005;81:S59-68.
  2. Sadeghi K, Berger A, Langgartner M, Prusa AR, Hayde M, Herkner K, et al. Immaturity of infection control in preterm and term newborns is associated with impaired toll-like receptor signaling. J Infect Dis. 2007;195:296-302.
  3. Palojärvi A, Petäjä J, Siitonen S, Janér C, Andersson S. Low monocyte HLA-DR expression as an indicator of immunodepression in very low birth weight infants. Pediatr Res. 2013;73:469-75.
  4. Singh VV, Chauhan SK, Rai R, Kumar A, Rai G. Decreased toll-like receptor-4/myeloid differentiation factor 88 response leads to defective interleukin-1ß production in term low birth weight newborns. Pediatr Infect Dis J. 2014;33:1270-6.
  5. Hjuler T, Wohlfahrt J, Simonsen J, Kaltoft MS, Koch A, Kamper-Jørgensen M, et al. Perinatal and crowding related risk factors for invasive pneumococcal disease in infants and young children: a population-based case-control study. Clin Infect Dis. 2007;44:1051-6.
  6. MacNeil JR, Cohn AC, Farley M, Mair R, Baumbach J, Bennett N, et al. Current epidemiology and trends in invasive Haemophilus influenzae disease–United States, 1989-2008. Clin Infect Dis. 2011;53:1230-6.
  7. Comité Asesor de Vacunas de la Asociación Española de Pediatría. Vacunación de niños prematuros. En: Manual de Vacunas en línea de la AEP [en línea] [consultado el 11/12/2015]. Disponible en: http://vacunasaep.org/documentos/manual/cap-10
  8. National Center for Immunization and Respiratory Diseases. General recommendations on immunization – recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep. 2011;60:1-64.
  9. Public Health Agency of Canada. Immunization of infants born prematurely. En: Canadian Immunization Guide [en línea] [consultado el 11/12/2015]. Disponible en: http://www.phac-aspc.gc.ca/publicat/cig-gci/p03-05-eng.php
  10. Public Health England. Immunisation of individuals with underlying medical conditions. The Green Book. Chapter 7. En: Gov.UK [en línea] [consultado el 11/12/2015]. Disponible en: https://www.gov.uk/government/publications/immunisation-of-individuals-with-underlying-medical-conditions-the-green-book-chapter-7
  11. Aparicio Rodrigo M, Martínez Rubio V. En la vacunación de los prematuros extremos, ¿los riesgos superan a los beneficios?. Evid Pediatr. 2015;11:64
  12. Lee J, Robinson JL, Spady DW. Frequency of apnea, bradycardia, and desaturations following first diphtheria-tetanus-pertussis-inactivated polio-Haemophilus influenza type b immunization in hospitalized preterm infants. BCM. 2006;6:20.
  13. Hacking DF, Davis PG, Wong E, Wheeler K, McVernon J. Frequency of respiratory deterioration after immunization y preterm infants. J Pediatr Child Health. 2010;46:742-8.
  14. Carbonye T, McEntire B, KissinD, Kelly D, Steinschneider A, Violaris K, et al. Absence of an increase in cardiorespiratory events after diphtheria-tetanus-acellular pertussis immunization in preterm infants: a randomized, multicenter study. Pediatrics. 2008;121:e1085-e1090.
  15. Shinefield H, Black S, Ray P, Fireman B, Schwalbe J, Lewis E. Efficacy, immunogenicity and safety of heptavalent pneumococcal conjugate vaccine in low birth weight and preterm infants. Pediatr Infect Dis J. 2002;21:182-6.
  16. Kuzniewicz MW, Klein NP. Differentiating sepsis from adverse events after immunization in the neonatal intensive care unit: how is a physician to know? JAMA Pediatr. 2015;196:718-9.
  17. Fine PE, Chen RT. Confounding in studies of adverse reactions to vaccines. Am J Epidemiol. 1992;136:121-35.
  18. Woestenberg PJ, van Lier A, van der Maas NA, Drijfhout IH, Oomen PJ, de Melker HE. Delayed start of diphtheria, tetanus, acellular pertussis and inactivated polio vaccination in preterm and low birth weight infants in the Netherland. Pediatr Infect Dis J. 2014;33:190-8.
  19. Amirthalingam G, Andrews N, Campbell H, Ribeiro S, Kara E, Donegan K, et al. Effectiveness of maternal pertussis vaccination in England: an observational study. Lancet. 2014;384:1521-8.
  20. Sizaire V, Garrido-Estepa M, Masa-Calles J, Martinez de Aragon MV. Increase of pertussis incidence in 2010 to 2012 after 12 years of low circulation in Spain. Euro Surveill. 2014;19(32).

Related Articles

AVC | In routine immunization of extremely premature infants: do the risks outweigh the benefits?

Aparicio Rodrigo M, Martínez Ruibo V. En la vacunación de los prematuros extremos, ¿los riesgos superan a los beneficios? Evid Pediatr. 2015;11:64.
16/12/2015

Linked Comment